These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15569996)
1. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. Chiappetta G; Botti G; Monaco M; Pasquinelli R; Pentimalli F; Di Bonito M; D'Aiuto G; Fedele M; Iuliano R; Palmieri EA; Pierantoni GM; Giancotti V; Fusco A Clin Cancer Res; 2004 Nov; 10(22):7637-44. PubMed ID: 15569996 [TBL] [Abstract][Full Text] [Related]
2. HMGA1 protein expression in familial breast carcinoma patients. Chiappetta G; Ottaiano A; Vuttariello E; Monaco M; Galdiero F; Gallipoli A; Pilotti S; Jodice G; Siranoush M; Colombo M; Ripamonti CB; Pallante PL; Radice P; Fusco A Eur J Cancer; 2010 Jan; 46(2):332-9. PubMed ID: 19896837 [TBL] [Abstract][Full Text] [Related]
3. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS; Kim SW Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359 [TBL] [Abstract][Full Text] [Related]
4. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
5. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression. Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840 [TBL] [Abstract][Full Text] [Related]
6. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
7. c-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinomas: an immunohistochemical study. Yokota T; Imamura M; Teshima S; Suzuki H; Tezuka F; Kikuchi S; Kunii Y; Yamauchi H Anticancer Res; 1999; 19(5B):4007-12. PubMed ID: 10628345 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of p53 expression in primary breast carcinomas. Naidu R; Yadav M; Nair S; Kutty KK Anticancer Res; 1998; 18(1A):65-70. PubMed ID: 9568057 [TBL] [Abstract][Full Text] [Related]
9. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion. Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors]. Zhang Z; Xu G; Liu S Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761 [TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast. Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078 [TBL] [Abstract][Full Text] [Related]
12. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast. Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317 [TBL] [Abstract][Full Text] [Related]
13. Detection by immunohistochemistry of c-erbB2 oncoprotein in breast carcinomas and benign mammary lesions. Edorh A; Leroux A; N'sossani B; Parache RM; Rihn B Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):831-40. PubMed ID: 10541479 [TBL] [Abstract][Full Text] [Related]
15. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
16. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer. Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2. Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976 [TBL] [Abstract][Full Text] [Related]
18. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310 [TBL] [Abstract][Full Text] [Related]
19. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast. Looi LM; Cheah PL; Yap SF Malays J Pathol; 1997 Jun; 19(1):35-9. PubMed ID: 10879240 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]. Meng J; Lang RG; Fan Y; Fu L Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):284-8. PubMed ID: 17760256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]